Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vincristine, carboplatin, and etoposide vs observation after surgery for newly diagnosed intraocular retinoblastoma; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Etoposide (Etoposide)
  • Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Intraocular Retinoblastoma | Phase 3 | Status: COMPLETED | Results posted: 2018-04-17